Advertisement

Topics

Taro Pharmaceuticals U.S.A., Inc. Company Profile

14:46 EDT 22nd September 2018 | BioPortfolio

Taro entered the U.S. market in 1988, after establishing its Canadian subsidiary in 1984 and receiving approval of its first topical product in the United States.The U.S. has become Taro’s largest market, accounting for more than 80% of our global sales. Our proprietary and generic U.S. products are both prescription and over-the-counter (OTC) medications, sold in Taro label and private-label (store brand). They include topical dermatological prescription pharmaceuticals (creams, ointments, gels, etc.), a category in which Taro is an acknowledged leader, as well as a growing line of oral dose drugs (tablets and capsules) used primarily in cardiovascular and neurological disorders.Taro U.S.A. maintains its own distribution facilities so that our U.S. customers, which include the largest drugstore chains and wholesalers, are assured of a continuous supply of Taro products. Taro's first U.S. research operations were established in 2003.Taro markets a broad range of prescription and over-the-counter products in the United States. We are a leading manufacturer and supplier of topical dermatological products and also have a growing line of solid dosage form products used mainly in cardiology and neurology.We’re proud that millions of Americans rely on our generic pharmaceuticals and over-the-counter private-label products every year. Whether you're a physician, pharmacist or patient, please consider this website your personal resource for learning more about Taro.

Location

3 Skyline Drive
Hawthorne
New York
10532
United States of America

Contact

Phone: 1-800-544-1449
Fax: 1-800-329-8276


News Articles [331 Associated News Articles listed on BioPortfolio]

Taro Annual Report on Form 20-F Available

For Fiscal Year Ended March 31, 2018 Taro Pharmaceutical Industries Ltd. (NYSE:TARO, “Taro”) announced that its Annual Report on Form 20-F for the fiscal year ended March ...

Taro to Announce First Quarter Results on August 9, 2018

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2018, after the close of market on T...

Kal Sundaram appointed as chairman of Taro Pharmaceutical

Taro Pharmaceutical Industries Ltd. (Taro) announced that Dilip Shanghvi has resigned, effective April 18, as chairman and a member of Taro's board of directors in order to focus on other growth prior...

Taro Pharmaceutical's (TARO) CEO Uday Baldota on Q4 2018 Results - Earnings Call Transcript

Taro to Announce Full Year Results on May 17, 2018

Earnings Call to Discuss Results to be Conducted Friday, May 18 at 8:00 am EDT Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release ...

Crescita’s US Prescription Product is “Launching Shortly,” says CEO

Crescita Therapeutics' new U.S. launch through its partner, Taro Pharmaceuticals of Pliaglis is just one of the many global expansions the company is expecting in the coming years. The post Crescita&#...

Taro Pharmaceutical Industries Ltd TARO Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 25042018] Prices from USD $250

SummaryTaro Pharmaceutical Industries Ltd Taro, a subsidiary of Sun Pharmaceutical Industries Ltd, research develops and markets healthcare products. The company manufactures prescription drugs, nonpr...

Deals and M&As this week: Aridis Pharmaceuticals, Xeris Pharmaceuticals, Astellas Pharma

Aridis Pharmaceuticals has raised $26m through an initial public offering of two million shares of its common stock priced at $13...Read More... The post Deals and M&As this week: Aridis Pharmac...

Drugs and Medications [378 Associated Drugs and Medications listed on BioPortfolio]

Clotrimazole [Taro Pharmaceuticals, Inc.]

Clotrimazole Topical Solution USP,1%

Clotrimazole [Taro Pharmaceuticals U.S.A., Inc.]

Clotrimazole Topical Solution USP,1%

Clotrimazole [Taro Pharmaceuticals, Inc.]

Clotrimazole Cream USP,1% Antifungal Cream

Clotrimazole [Taro Pharmaceuticals U.S.A., Inc.]

Clotrimazole Cream USP,1% Antifungal Cream

Cetirizine hydrochloride [Taro Pharmaceuticals U.S.A., Inc.]

Children's Cetirizine Hydrochloride Oral Solution

PubMed Articles [152 Associated PubMed Articles listed on BioPortfolio]

Taro starch (Colocasia esculenta) and citric acid modified taro starch as tablet disintegrating agents.

The objective of the present work is to study the physicochemical and functional properties of taro starch (Colocasia esculenta) and to further modify the starch by treating with citric acid to obtain...

Literary evidence for taro in the ancient Mediterranean: A chronology of names and uses in a multilingual world.

Taro, Colocasia esculenta (L.) Schott, is a vegetable and starchy root crop cultivated in Asia, Oceania, the Americas, Africa, and the Mediterranean. Very little is known about its early history in th...

Adsorption of Cu (II) and Ni (II) from aqueous solutions by taro stalks chemically modified with diethylenetriamine.

Taro stalks (TS) were modified by diethylenetriamine (DETA) to obtain the modified taro stalks adsorbents (recorded as MTSA). This kind of raw material is unprecedented and the method of modification ...

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

Physical stabilities of taro starch nanoparticles stabilized Pickering emulsions and the potential application of encapsulated tea polyphenols.

In this research, Pickering emulsion stabilized by taro starch nanoparticles was successfully prepared, and the potential application of encapsulating tea polyphenols was investigated. The nanoparticl...

Clinical Trials [223 Associated Clinical Trials listed on BioPortfolio]

A Therapeutic Equivalence Study of Two Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis

The primary objectives are to establish the therapeutic equivalence of imiquimod cream 5%, manufactured by Taro Pharmaceuticals Inc. and Aldara (imiquimod) cream, manufactured by 3M, and t...

Clinical Equivalence of Two Butenafine Hydrochloride 1% Creams in Patients With Interdigital Tinea Pedis

To demonstrate comparable safety and efficacy of Taro Pharmaceuticals Inc. butenafine hydrochloride cream 1% (test product) and Lotrimin Ultra® cream (reference listed drug) in the treatm...

Clinical Study to Evaluate the Efficacy and Safety of DSXS With Atopic Dermatitis

Efficacy and Safety of DSXS (Taro Pharmaceuticals, U.S.A., Inc.) in Patients with Moderate to Severe Atopic Dermatitis

Pharmacokinetics of Malathion Gel 0.5% and Malathion 0.5% Lotion (Ovide) in Patients With Head Lice

In this study, 24 adult patients with head lice will be treated with a topical malathion head lice treatment; 12 patients will be treated with a novel product, Malathion Gel, 0.5%, and oth...

Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product

An Open-Label, Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use DSXS topical product (Taro Pharmaceuticals U.S.A., Inc.) in Patients with Moderate to Seve...

Companies [1332 Associated Companies listed on BioPortfolio]

Taro Pharmaceuticals U.S.A., Inc.

Taro entered the U.S. market in 1988, after establishing its Canadian subsidiary in 1984 and receiving approval of its first topical product in the United States.The U.S. has become Taro’s largest m...

Taro Pharmaceutical Ind.

Taro markets a broad range of prescription and over-the-counter products in the United States. We are a leading manufacturer and supplier of topical dermatological products and also have a growing li...

 Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries develops, manufactures, and markets high-quality generic and branded pharmaceuticals, both prescription and over-the-counter, used by patients in countries around the wo...

Sun Pharmaceuticals, Inc., Taro Pharmaceutical Industries Ltd.

Established in 1983, listed since 1994 and headquartered in India, Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) is an international, integr...

More Information about "Taro Pharmaceuticals U.S.A., Inc." on BioPortfolio

We have published hundreds of Taro Pharmaceuticals U.S.A., Inc. news stories on BioPortfolio along with dozens of Taro Pharmaceuticals U.S.A., Inc. Clinical Trials and PubMed Articles about Taro Pharmaceuticals U.S.A., Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Taro Pharmaceuticals U.S.A., Inc. Companies in our database. You can also find out about relevant Taro Pharmaceuticals U.S.A., Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...


Corporate Database Quicklinks



Searches Linking to this Company Record